We are live on ! Find out more
FA

Friess Associates Portfolio holdings

AUM $59.9M
1-Year Est. Return 3.42%
This Fund
S&P 500
This Quarter Est. Return
+16.23%
1 Year Est. Return
+3.42%
3 Year Est. Return
+255.77%
5 Year Est. Return
+639.06%
10 Year Est. Return
AUM
$265M
AUM Growth
+$7.91M
Cap. Flow
-$8.01M
Cap. Flow %
-3.02%
Top 10 Hldgs %
28.73%
Holding
124
New
32
Increased
19
Reduced
34
Closed
37

Top Buys

Rank Stock Value
1
HOV icon
Hovnanian Enterprises
HOV
+$8.63M
2
AXGN icon
Axogen
AXGN
+$5.23M
3
ACMR icon
ACM Research
ACMR
+$4.71M
4
SWIM icon
Latham Group
SWIM
+$4.37M
5
CRMT icon
America's Car Mart
CRMT
+$4.14M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 25.25%
2 Technology 18.87%
3 Industrials 18%
4 Healthcare 17.58%
5 Communication Services 8.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRWG icon
1
GrowGeneration
GRWG
$84.1M
$9.15M 3.45%
190,140
-55,304
-23% -$2.42M
AWH
2
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$8.11M 3.06%
96,190
+4,475
+5% +$384K
MGNI icon
3
Magnite
MGNI
$2.59B
$7.91M 2.98%
233,613
+78,621
+51% +$2.66M
HOV icon
4
Hovnanian Enterprises
HOV
$756M
$7.89M 2.98%
+74,275
New +$8.63M
TBHC
5
DELISTED
The Brand House Collective
TBHC
$7.88M 2.97%
344,471
-47,446
-12% -$1.28M
SIEN
6
DELISTED
Sientra, Inc.
SIEN
$7.78M 2.94%
97,792
-1,116
-1% -$79.3K
CYRX icon
7
CryoPort
CYRX
$805M
$7.55M 2.85%
119,656
+16,013
+15% +$901K
HYRE
8
DELISTED
HyreCar Inc. Common Stock
HYRE
$7.03M 2.65%
336,021
-183,887
-35% -$2.83M
TGLS icon
9
Tecnoglass
TGLS
$1.94B
$6.44M 2.43%
300,826
+125,756
+72% +$2.08M
IMMR icon
10
Immersion
IMMR
$217M
$6.41M 2.42%
731,142
+126,650
+21% +$1.09M
CIVI
11
DELISTED
Civitas Resources
CIVI
$6.23M 2.35%
132,378
-35,022
-21% -$1.42M
NPTN
12
DELISTED
NEOPHOTONICS CORP
NPTN
$5.98M 2.26%
586,126
+34,492
+6% +$364K
ACMR icon
13
ACM Research
ACMR
$6.04B
$5.84M 2.2%
+171,300
New +$4.71M
AXGN icon
14
Axogen
AXGN
$2.09B
$5.59M 2.11%
+258,874
New +$5.23M
PLXP
15
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$5.01M 1.89%
362,922
+59,522
+20% +$705K
CLGN icon
16
CollPlant Biotechnologies
CLGN
$5.86M
$4.99M 1.88%
235,092
-14,999
-6% -$240K
SWIM icon
17
Latham Group
SWIM
$655M
$4.78M 1.8%
+149,662
New +$4.37M
IHRT icon
18
iHeartMedia
IHRT
$541M
$4.78M 1.8%
+177,302
New +$3.92M
ASO icon
19
Academy Sports + Outdoors
ASO
$2.91B
$4.7M 1.77%
+114,003
New +$3.99M
STIM icon
20
Neuronetics
STIM
$129M
$4.67M 1.76%
291,700
-147,267
-34% -$2.03M
PXLW icon
21
Pixelworks
PXLW
$38.2M
$4.31M 1.63%
+105,417
New +$4.14M
GTES icon
22
Gates Industrial Corporation Ltd.
GTES
$6.85B
$4.25M 1.6%
234,987
+106,353
+83% +$1.86M
CALX icon
23
Calix
CALX
$2.26B
$4.22M 1.59%
88,808
-40,797
-31% -$1.79M
YETI icon
24
Yeti Holdings
YETI
$3.8B
$4.16M 1.57%
45,275
+18,403
+68% +$1.6M
CRMT icon
25
America's Car Mart
CRMT
$29.4M
$3.92M 1.48%
+27,632
New +$4.14M

Similar funds

Friess Associates's Q2 2021 Portfolio in Review

As of Q2 2021, Friess Associates held 124 positions worth $265M, up 3.1% from $257M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Friess Associates withdrew a net $8.01M in Q2 2021, closing 37 positions and reducing 34 holdings. Its most notable exit was DZS Inc. Common Stock, an estimated $4.6M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 25% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.

Against the trend, Friess Associates opened a new position in Hovnanian Enterprises worth $7.89M.

  • Friess Associates's largest Q2 2021 buy was Hovnanian Enterprises: 74,275 shares worth $7.89M.
  • Friess Associates added most to Magnite in Q2 2021, an estimated $2.66M increase.
  • Friess Associates's biggest Q2 2021 reduction was Ichor Holdings, cutting an estimated $3.74M.
  • Friess Associates fully exited DZS Inc. Common Stock in Q2 2021, selling an estimated $4.6M.
  • Friess Associates's ten largest holdings make up 29% of its $265M portfolio in Q2 2021.
  • Friess Associates opened 32 new positions and closed 37 in Q2 2021.
  • Friess Associates's portfolio value rose 3.1% quarter-over-quarter to $265M.

Based on Friess Associates's 13F filing for Q2 2021, filed 11 Aug 2021.